98
IRUS Total
Downloads
  Altmetric

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

File Description SizeFormat 
RESUB_PC_OncoArray_Main_FINAL_WORD.docxAccepted version3.49 MBMicrosoft WordView/Open
Title: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Authors: Schumacher, FR
Al Olama, AA
Berndt, SI
Benlloch, S
Ahmed, M
Saunders, EJ
Dadaev, T
Leongamornlert, D
Anokian, E
Cieza-Borrella, C
Goh, C
Drake, BF
Vega, A
Gómez-Caamaño, A
Szulkin, R
Eklund, M
Kogevinas, M
Llorca, J
Castaño-Vinyals, G
Penney, KL
Røder, MA
Canary PASS Investigators
Stampfer, M
Park, JY
Sellers, TA
Lin, H-Y
Stanford, JL
Cybulski, C
Iversen, P
Brook, MN
Brenner, H
Cuk, K
Breast and Prostate Cancer Cohort Consortium (BPC3)
Holleczek, B
Maier, C
Luedeke, M
Schnoeller, T
Kim, J
Logothetis, CJ
John, EM
Teixeira, MR
Sheng, X
Paulo, P
PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium
Cardoso, M
Neuhausen, SL
Steele, L
Ding, YC
De Ruyck, K
De Meerleer, G
Ost, P
Razack, A
Lim, J
Fachal, L
Cancer of the Prostate in Sweden (CAPS)
Teo, S-H
Lin, DW
Newcomb, LF
Lessel, D
Gamulin, M
Kulis, T
Kaneva, R
Usmani, N
Singhal, S
Slavov, C
Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS)
Dennis, J
Mitev, V
Parliament, M
Claessens, F
Joniau, S
Van den Broeck, T
Larkin, S
Townsend, PA
Aukim-Hastie, C
Dominguez, MG
Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium
Castelao, JE
Tyrer, J
Martinez, ME
Roobol, MJ
Jenster, G
Van Schaik, RHN
Menegaux, F
Truong, T
Koudou, YA
Profile Study
Amos, CI
Xu, J
Khaw, K-T
Muir, K
Cannon-Albright, L
Pandha, H
Michael, A
Thibodeau, SN
McDonnell, SK
Schaid, DJ
Lindstrom, S
Conti, DV
Turman, C
Ma, J
Hunter, DJ
Lophatananon, A
Riboli, E
Siddiq, A
Canzian, F
Kolonel, LN
Le Marchand, L
Hoover, RN
Easton, DF
Machiela, MJ
Cui, Z
Kraft, P
Australian Prostate Cancer BioResource (APCB)
Stevens, VL
IMPACT Study
Gapstur, SM
Wokolorczyk, D
Wiklund, F
Chanock, SJ
Henderson, BE
Kote-Jarai, Z
Haiman, CA
Eeles, RA
Carter, BD
Tangen, CM
Goodman, PJ
Thompson, IM
Lubinski, J
Batra, J
Chambers, S
Moya, L
Clements, J
Horvath, L
Tilley, W
Risbridger, GP
Gronberg, H
Aly, M
Nordström, T
Ostrander, EA
Pharoah, P
Pashayan, N
Schleutker, J
Tammela, TLJ
Sipeky, C
Auvinen, A
Albanes, D
Weinstein, S
Wolk, A
Håkansson, N
Geybels, MS
West, CML
Dunning, AM
Burnet, N
Mucci, LA
Giovannucci, E
Andriole, GL
Cussenot, O
Cancel-Tassin, G
Koutros, S
Beane Freeman, LE
Nordestgaard, BG
Sorensen, KD
Orntoft, TF
Borre, M
Maehle, L
Grindedal, EM
Neal, DE
Donovan, JL
Hamdy, FC
Martin, RM
Travis, RC
Nielsen, SF
Key, TJ
Hamilton, RJ
Fleshner, NE
Finelli, A
Ingles, SA
Stern, MC
Rosenstein, BS
Kerns, SL
Ostrer, H
Lu, Y-J
Weischer, M
Zhang, H-W
Feng, N
Mao, X
Guo, X
Wang, G
Sun, Z
Giles, GG
Southey, MC
MacInnis, RJ
FitzGerald, LM
Bisbjerg, R
Kibel, AS
Item Type: Journal Article
Abstract: Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data from a custom high-density array of 46,939 PrCa cases and 27,910 controls of European ancestry with previously genotyped data of 32,255 PrCa cases and 33,202 controls of European ancestry. Our analysis identified 62 novel loci associated (P < 5.0 × 10-8) with PrCa and one locus significantly associated with early-onset PrCa (≤55 years). Our findings include missense variants rs1800057 (odds ratio (OR) = 1.16; P = 8.2 × 10-9; G>C, p.Pro1054Arg) in ATM and rs2066827 (OR = 1.06; P = 2.3 × 10-9; T>G, p.Val109Gly) in CDKN1B. The combination of all loci captured 28.4% of the PrCa familial relative risk, and a polygenic risk score conferred an elevated PrCa risk for men in the ninetieth to ninety-ninth percentiles (relative risk = 2.69; 95% confidence interval (CI): 2.55-2.82) and first percentile (relative risk = 5.71; 95% CI: 5.04-6.48) risk stratum compared with the population average. These findings improve risk prediction, enhance fine-mapping, and provide insight into the underlying biology of PrCa 1 .
Issue Date: 11-Jun-2018
Date of Acceptance: 5-Apr-2018
URI: http://hdl.handle.net/10044/1/60278
DOI: https://doi.org/10.1038/s41588-018-0142-8
ISSN: 1061-4036
Publisher: Nature Publishing Group
Start Page: 928
End Page: 936
Journal / Book Title: Nature Genetics
Volume: 50
Copyright Statement: © 2018 Nature America Inc., part of Springer Nature. All rights reserved. The final publication is available at Springer via https://doi.org/10.1038/s41588-018-0142-8
Sponsor/Funder: Imperial College Trust
Funder's Grant Number: P47328
Keywords: Science & Technology
Life Sciences & Biomedicine
Genetics & Heredity
GENOME-WIDE ASSOCIATION
MULTIPLE LOCI
RISK
GENE
METAANALYSIS
VARIANTS
PATHWAY
IDENTIFICATION
CONSORTIUM
PREDICTION
Case-Control Studies
Genetic Loci
Genetic Predisposition to Disease
Genome-Wide Association Study
Genotype
Humans
Male
Polymorphism, Single Nucleotide
Prostatic Neoplasms
Risk
Profile Study
Australian Prostate Cancer BioResource (APCB)
IMPACT Study
Canary PASS Investigators
Breast and Prostate Cancer Cohort Consortium (BPC3)
PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium
Cancer of the Prostate in Sweden (CAPS)
Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS)
Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium
Humans
Prostatic Neoplasms
Genetic Predisposition to Disease
Risk
Case-Control Studies
Genotype
Polymorphism, Single Nucleotide
Male
Genome-Wide Association Study
Genetic Loci
Developmental Biology
11 Medical and Health Sciences
06 Biological Sciences
Publication Status: Published
Conference Place: United States
Online Publication Date: 2018-06-11
Appears in Collections:School of Public Health